NCT01909778View on ClinicalTrials.gov

Open Label Single Dose Phase I Trial of BI 201335 to Study Pharmacokinetics and Safety in Patients With Compensated Liver Cirrhosis

PHASE1CompletedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
Hepatitis CLiver Cirrhosis
Interventions
DRUG

BI 201335

single oral doses

Trial Locations (1)

Unknown

1220.15.49006 Boehringer Ingelheim Investigational Site, Mainz

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT01909778 - Open Label Single Dose Phase I Trial of BI 201335 to Study Pharmacokinetics and Safety in Patients With Compensated Liver Cirrhosis | Biotech Hunter | Biotech Hunter